Abstral (AB-stral) will be the fourth immediate-release fentanyl

May 2011

Abstral (AB-stral) will be the fourth immediate-release fentanyl.

This sublingual tab will compete with the lozenge (Actiq, etc)...buccal tab (Fentora, etc)...and buccal film (Onsolis).

These are ONLY for breakthrough pain in cancer patients who are already on chronic opioids.

Get concise, unbiased advice for effective drug therapy, plus CE/CME

Prescriber Insights: APRN includes:

Cutting-edge advice about new medications and how they fit into practice
Unbiased, evidence-based, 100% free of financial support from the pharma industry written by your peers
Side-by-side comparisons of drugs by class or disease state, plus FAQs, pros/cons, and simple recommendations

Subscribe Today!

Already a subscriber? Log in

Volume pricing available. Get a quote

Table of Contents

Infectious Diseases GENERIC levofloxacin (Levaquin) beginning in June
Allergic Reactions true allergy to iodine is a medical myth
Cardiology how aggressively to treat cardiovascular risk factors in diabetes patients
Vaccines YOUNGER people are now candidates for Zostavax to prevent shingles
Antithrombotics whether patients should stop anticoagulant or antiplatelet meds before dental procedures
Antithrombotics Patients can now keep Pradaxa (dabigatran) for 60 days after the bottle is opened
Psychiatry systemic corticosteroids can cause adverse CNS effects
Oral Health Xerese (zuh-REES), a new Rx topical product for herpes simplex labialis
Women's Health when to use metformin or pioglitazone for polycystic ovary syndrome (PCOS)
Lupus lupus patients put on a new IV monoclonal antibody, Benlysta (ben-LIST-a, belimumab)
Neurology & Pain Abstral (AB-stral) will be the fourth immediate-release fentanyl
Asthma inhaled corticosteroids PRN for children with MILD persistent asthma